Deerfield Management UFPT Position
ActiveDeerfield Management trimmed their position in UFP TECHNOLOGIES INC (UFPT) in Q4 2025, holding $1.1M worth of shares across 5,098 shares.
The position was first reported in Q2 2025 and has been tracked across 3 quarterly 13F filings.
Short interest stands at 18.7% of float with 5.1 days to cover, indicating significant bearish positioning against Deerfield's long thesis.
About UFP TECHNOLOGIES INC
UFP Technologies, Inc. designs and custom manufactures components, subassemblies, products, and packaging utilizing specialized foams, films, and plastics primarily for the medical market. Its single-use and single-patient devices and components are used in a range of medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging. The company also provides engineered products and components to customers in the automotive, aerospace and defense, consumer, electronics, and industrial markets, which are applied in military uniform and gear components, automotive interior trim, athletic padding, environmentally protective packaging, air filtration, abrasive nail files, and protective cases and inserts. It markets and sells its products in the United States principally through a direct sales force, as well as independent manufacturer representatives. The company was founded in 1963 and is headquartered in Newburyport, Massachusetts.
Full company profile →Short Interest
18.7%
5.1 days to cover
Deerfield Management UFPT Position History
Frequently Asked Questions
Does Deerfield Management own UFPT?
Yes. As of Q4 2025, Deerfield Management holds 5,098 shares of UFP TECHNOLOGIES INC (UFPT) valued at $1.1M. This data comes from their SEC 13F filing.
How many hedge funds own UFPT?
1 specialist biotech hedge fund currently holds UFPT. When 3 or more specialist funds hold the same stock, BiotechEdge flags it as a convergence signal.
When did Deerfield Management first buy UFPT?
Deerfield Management's position in UFPT was first reported in Q2 2025. 13F filings are reported with a 45-day delay, so the actual purchase may have occurred earlier in the quarter.
Is Deerfield Management's UFPT position increasing or decreasing?
Deerfield Management trimmed their UFPT position in the most recent quarter, reducing by 13,562 shares.
Get the weekly biotech signal briefing
Fund moves, convergence shifts, insider buys, and catalyst alerts — delivered free every Monday.
UFPTCompany Page →
All fund holders, insider trades, catalysts, and cash runway
Deerfield ManagementPortfolio →
Full 13F holdings, sector breakdown, and top movers
Drill into any signal
Fund Convergence
See which stocks multiple specialist funds are buying at once
Catalyst Calendar
Every PDUFA date, Phase 3 readout, and AdCom in one view
Insider Trading
When executives buy their own stock — the strongest bullish signal
Cash Runway
Which biotechs are running low on cash and face dilution risk
Short Squeeze
High short interest + fund buying + upcoming catalyst = squeeze setup
Signal Rankings
Every signal in one composite score — ranked by conviction
Biotech Movers
Stocks with the most signal activity right now across all signals
13F Changes
What top biotech funds bought and sold in the latest 13F filing
Want AI context on every signal? Start free trial →